CCM
ALXN

Community Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Community Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,886
Closed -$247K – 161
2019
Q2 		$247K Hold
1,886
– – 0.28% 109
2019
Q1 		$255K Buy
+1,886
New +$235K 0.31% 110

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Community Capital Management's ALXN Position: Q3 2019 in Review

Community Capital Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2019, closing a stake of 1,886 shares — an estimated $247K sold.

Community Capital Management first reported a position in ALXN in Q1 2019 and held it in 2 quarters. The position peaked at $255K in Q1 2019. 646 funds tracked by Wall St. Rank hold ALXN as of Q3 2019.

  • Community Capital Management reported no remaining Alexion Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Community Capital Management sold 1,886 Alexion Pharmaceuticals shares in Q3 2019, an estimated $247K.
  • Community Capital Management first reported a position in Alexion Pharmaceuticals in Q1 2019 and held it in 2 quarters.
  • Community Capital Management's Alexion Pharmaceuticals position peaked at $255K in Q1 2019.
  • 646 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2019.

Based on Community Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.